Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAP-Targeted Radionuclide Imaging in Malignant Solid Tumors
NCT07707999Phase 1Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in malignant solid tumor. Primary endpoint: Visual and standardized uptake values assessment of lesions and biodistribution at 1 month. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT07707999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07707999.